Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bowen's Disease × Fluorouracil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 233 Rectal Neoplasms 142 Colonic Neoplasms 116 Stomach Neoplasms 88 Pancreatic Neoplasms 84 Esophageal Neoplasms 70 Breast Neoplasms 66 Neoplasm Metastasis 51 Head and Neck Neoplasms 48 Squamous Cell Carcinoma of Head and Neck 47 Neoplasms 38 Adenocarcinoma Of Esophagus 33 Esophageal Squamous Cell Carcinoma 25 Adenocarcinoma 23 Carcinoma, Hepatocellular 13 Unspecified Adult Solid Tumor, Protocol Specific 12 Keratosis, Actinic 11 Anus Neoplasms 11 Gastrointestinal Neoplasms 10 Gallbladder Neoplasms 10 Biliary Tract Neoplasms 10 Urinary Bladder Neoplasms 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Nasopharyngeal Carcinoma 9 Liver Neoplasms 9 Bile Duct Neoplasms 9 Cholangiocarcinoma 8 Carcinoma, Squamous Cell 8 Recurrence 7 Peritoneal Neoplasms 7

Interventions

methyl 5-aminolevulinate 3 Tomography, Optical Coherence 1 SR-T100 1 Photochemotherapy 1 Myelin and Lymphocyte-Associated Proteolipid Proteins 1 Lidocaine, Prilocaine Drug Combination 1 Lidocaine 1 Fluorouracil 1 Epinephrine 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03909646 2025-05-06

BOWTIE

Maastricht University Medical Center

Phase 4 Completed

Bowen's Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡